Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,606.49
(
-0.27%
)
US TECH 100
23,763.96
(
-0.13%
)
Dow Jones
46,021.43
(
-0.44%
)
Brent Oil
102.47
(
-1.88%
)
Bitcoin
70,399.00
(
0.72%
)
News Focus
News Focus
Post# of 257262
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

ciotera

Send PM Follow Ignore
Followers 8
Posts 512
Boards Moderated 0
Alias Born 08/03/2005

ciotera

Re: DewDiligence post# 185227

Monday, 12/29/2014 5:14:03 PM

Monday, December 29, 2014 5:14:03 PM

Post# of 257262
GILD/JNJ

This is definitely a step in the right direction as far as defending against Triumeq. Best in class PI based single tablet regimen will have a lot of appeal. But it does cut into their main future product (TAF based Stribild) which is now vulnerable to both Triumeq and Prezista/TAF.
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now